Himadri Speciality Chemical to host analyst meet on Sep 28
- Himadri Speciality Chemical Ltd will hold virtual analyst meetings on September 28, 2026
- Interactions include both one-on-one and group sessions with institutional investors
- Discussions will be limited to publicly available information per SEBI regulations
- The meeting schedule was filed with stock exchanges and posted on the company website

*this image is generated using AI for illustrative purposes only.
Himadri Speciality Chemical Ltd will engage with analysts and institutional investors in virtual meetings on September 28, 2026. The company plans to conduct both one-on-one and group interactions as part of its investor outreach strategy.
Meeting details and format
The interaction is scheduled under the framework of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Discussions will be restricted to publicly available information, ensuring no unpublished price sensitive information is disclosed during the sessions.
| Date | Event Details | Mode of Interaction | Type of Interaction |
|---|---|---|---|
| September 28, 2026 | Goldman Sachs India – Hidden Gems | Virtual | One on One & Group Meeting |
Compliance and disclosures
The schedule has been filed with the stock exchanges and placed on the company's website. The company noted that the meeting schedule may undergo changes due to exigencies on the part of the analysts, investors, or the company itself. Monika Saraswat, Company Secretary and Compliance Officer, signed the intimation dated September 23, 2026.
Historical Stock Returns for Himadri Speciality Chemical
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.21% | +0.02% | -0.74% | +40.16% | +44.90% | +1,196.66% |
How might Goldman Sachs' 'Hidden Gems' designation influence Himadri Speciality Chemical's institutional ownership ratio in the upcoming quarters?
What specific growth catalysts or capacity expansion projects is the company likely to highlight to attract new long-term investors during these sessions?
Will the increased analyst coverage following this event lead to a re-rating of the company's valuation multiples relative to its speciality chemical peers?
































